Understanding HER2-Low mBC
ESMO 2022 on DESTINY-Breast04 Patient-Reported Outcomes: T-DXd vs. TPC in HER2-Low mBC
By
ESMO 2022 Conference Coverage
FEATURING
Naoto Ueno
By
ESMO 2022 Conference Coverage
FEATURING
Naoto Ueno
Comments 0
Login to view comments.
Click here to Login